Type VI secretion system mutations reduced competitive fitness of classical Vibrio cholerae biotype
Nat Commun. 2021 Nov 9;12(1):6457
MMI Publications, Awards, and other Achievements
Recent Posts
Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2
Nat Chem Biol. 2021 Nov 9
Knowledge Gaps in the Understanding of Antimicrobial Resistance in Canada
Front Public Health. 2021 Oct 20;9:726484
Improved SARS-CoV-2 M pro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies
Eur J Med Chem. 2021 Oct 15;222:113584
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1
Vaccine. 2021 Sep 24;39(40):5769-5779
Integrating Reverse Transcription Recombinase Polymerase Amplification with CRISPR Technology for the One-Tube Assay of RNA
Anal Chem. 2021 Sep 21;93(37):12808-12816
Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors
RSC Med Chem. 2021 Aug 20;12(10):1722-1730
Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection
PLoS Biol. 2021 Aug 19;19(8):e3001387.
CRISPR Technique Incorporated with Single-Cell RNA Sequencing for Studying Hepatitis B Infection
Anal Chem. 2021 Aug 10;93(31):10756-10761.
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
NPJ Precis Oncol. 2021 Jul 14;5(1):64.
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
J Infect Dis. 2021 Jul 15;224(Supplement_1):S1-S21.
Remdesivir for the treatment of Covid-19: the value of biochemical studies
Curr Opin Virol 2021 Aug;49:81-85 (ePub May 12)
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
Lancet Respir Med 2021 May;9(5):498-510.
Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.
COVID-19: Sci Adv 2021 Feb 5;7(6)):eabe7386.
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
Viruses. 2020 Dec 26;13(1):29.
COVID-19: Anal Chem. 2020 Dec 15;92(24)
Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology
COVID-19: Nat Genet 2020 Dec;52(12)
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
COVID-19: J Biol Chem 2020 Nov 20;295(47)
Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
COVID-19: Proc Natl Acad Sci U S A. 2020 Nov 10;117(45)
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
COVID-19: Proc Natl Acad Sci U S A. 2020 Oct 27;117(43)
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
COVID-19: mBio. 2020 Oct 23;11(5)
The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic
COVID-19: J. Immunol. 2020 Oct 15;205(8)
Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy
COVID-19: Nat. Commun. 2020 Aug 27;11(1)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
COVID-19: Anal Chem 2020 Aug 4;92(15)
Molecular Diagnosis of COVID-19: Challenges and Research Needs
COVID-19: Am J Trop Med Hyg 2020 Jun;102(6)
Nonessential Research in the New Normal: The Impact of COVID-19
COVID-19: J. Biol. Chem. 2020 May 15;295(20)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
COVID-19: J. Exp. Med. 2020 May 4;217(5)
COVID-19 and emerging viral infections: The case for interferon lambda
COVID-19: J Biol Chem 2020 Apr 10;295(15)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus